Author:
Li Qianping,Wang Jianjun,Zhang Jun,Lin Chengyi
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61: 69–90.
2. Nakajima E, Katou H. Adjuvant chemotherapy for resectable nonsmall cell lung cancer (NSCLC). Kyobu Geka, 2008, 61: 4–8.
3. Spasova I, Petera J, Hytych V. The role of neoadjuvant chemotherapy in marginally resectable or unresectable stage III non-small cell lung cancer. Neoplasma, 2002, 49: 189–196.
4. Watanabe H, Yamamoto S, Kunitoh H, et al. Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci, 2003, 94: 1015–1020.
5. Garrido P, Gonzalez-Larriba JL, Insa A, et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol, 2007, 25: 4736–4742.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献